Establishing the efficacy and safety of the novel use of common salt for the treatment of pyogenic granuloma.
Journal
Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
revised:
21
03
2021
received:
15
01
2021
accepted:
22
03
2021
pubmed:
26
3
2021
medline:
8
1
2022
entrez:
25
3
2021
Statut:
ppublish
Résumé
Recurrent bleeding episodes are often a cause of significant anxiety in patients with pyogenic granuloma (PG). The idea of using common salt for the treatment of PG arose from the need for a relatively safe and effective treatment because of the recurrent nature of the lesion. A prospective open-label uncontrolled study of 50 patients was conducted. All cases were treated with ordinary table salt from a commercially available package. White soft paraffin was first applied over the perilesional skin, then sufficient salt to cover the entire lesion was applied and the area was occluded with surgical adhesive tape. All patients were followed up for any complications or recurrence. Complete resolution of the lesion without any residual scar was seen in 100% of the cases, and 94% reported a decrease in the bleeding tendency of the lesion as an immediate response. The mean time to complete resolution was 14.77 days. Recurrence was noted in one patient after 11 months of resolution. Owing to the relative ease in application, lack of scarring and excellent response, we consider salt application to be an ideal treatment for PG lesions, especially in children and anxious patients reluctant to undergo any procedure.
Sections du résumé
BACKGROUND
BACKGROUND
Recurrent bleeding episodes are often a cause of significant anxiety in patients with pyogenic granuloma (PG). The idea of using common salt for the treatment of PG arose from the need for a relatively safe and effective treatment because of the recurrent nature of the lesion.
METHODS
METHODS
A prospective open-label uncontrolled study of 50 patients was conducted. All cases were treated with ordinary table salt from a commercially available package. White soft paraffin was first applied over the perilesional skin, then sufficient salt to cover the entire lesion was applied and the area was occluded with surgical adhesive tape. All patients were followed up for any complications or recurrence.
RESULTS
RESULTS
Complete resolution of the lesion without any residual scar was seen in 100% of the cases, and 94% reported a decrease in the bleeding tendency of the lesion as an immediate response. The mean time to complete resolution was 14.77 days. Recurrence was noted in one patient after 11 months of resolution.
CONCLUSION
CONCLUSIONS
Owing to the relative ease in application, lack of scarring and excellent response, we consider salt application to be an ideal treatment for PG lesions, especially in children and anxious patients reluctant to undergo any procedure.
Substances chimiques
Sodium Chloride, Dietary
0
Types de publication
Clinical Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1243-1247Informations de copyright
© 2021 British Association of Dermatologists.
Références
Wollina U, Langner D, França K et al. Pyogenic granuloma - a common benign vascular tumor with variable clinical presentation: new findings and treatment options. Open Access Maced J Med Sci 2017; 5: 423-6.
Hasanoglu Erbasar GN, Senguven B, Gultekin SE, Cetiner S. Management of a recurrent pyogenic granuloma of the hard palate with diode laser: a case report. J Lasers Med Sci 2016; 7: 56-61.
Daruwalla SB, Dhurat RS. A pinch of salt is all it takes! The novel use of table salt for the effective treatment of pyogenic granuloma. J Am Acad Dermatol 2020; 83: e107-8.
Sarwal P, Lapumnuaypol K. Pyogenic granuloma. Available at: https://www.statpearls.com/kb/viewarticle/28105 (accessed 2 January 2021).
Schmitt BD. Tip of the month, shrinking umbilical granulomas. Consultant 1972; 12: 91.
Kesaree N, Babu PS, Banapurmath CR, Krishnamurthy SN. Umbilical granuloma. Indian Pediatr 1983; 20: 690-2.
Lin RL, Janniger CK. Pyogenic granuloma. Cutis 2004; 74: 229-33.
Yang C, Liu S. Treatment of giant pyogenic granuloma with the Nd/YAG holmium laser: a case report. J Cosmet Laser Ther 2013; 15: 225-7.
Gencoglan G, Inanir I, Gündüz K. Pyogenic granuloma in two children successfully treated with imiquimod 5% cream. Pediatr Dermatol 2009; 26: 366-8.
Tritton SM, Smith S, Wong LC et al. Pyogenic granuloma in ten children treated with topical imiquimod. Pediatr Dermatol 2009; 26: 269-72.
Lee J, Sinno H, Tahiri Y, Gilardino MS. Treatment options for cutaneous pyogenic granulomas: a review. J Plast Reconstructr Aesthet Surg 2011; 64: 1216-20.
Gilmore A, Kelsberg G, Safranek S. What’s the best treatment for pyogenic granuloma? J Fam Pract 2010; 59: 40-2.
Scheinfeld NS. Pyogenic granuloma. Skinmed 2008; 7: 89-92.
Spinelli C, Di Giacomo M, Bertocchini A et al. Multiple pyogenic granuloma of the penis in a four-year-old child: a case report. Cases J 2009; 2: 7831.